Sabina Carla Righetti

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

Valentina Zuco, Rosanna Supino, Sabina Carla Righetti et al. · Cancer Letters · 2002 · 521 citations

Tumor Biology, Oncogenic Agent, Medicine +9

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Paola Perego, Monica Giarola, Sabina Carla Righetti et al. · PubMed · 1996 · 392 citations

P53 Status, Reduced Bax Expression, Pathology +16

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.

Sabina Carla Righetti, Gabriella Della Torre, S. Pilotti et al. · PubMed · 1996 · 281 citations

Medicine, P53 Gene Mutations, Pathology +14

A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431

Annalisa Castagna, Paolo Antonioli, Hubert Astner et al. · PROTEOMICS · 2004 · 140 citations

Proteomic Approach, Cancer Biology, Tumor Biology +17

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

Graziella Pratesi, Paola Perego, Donatella Polizzi et al. · British Journal of Cancer · 1999 · 116 citations · Full text